Platelet count, platelet turnover and fibrin clot structure in patients with coronary artery disease

Thrombosis Research

Volumn 133, Issue 6, 2014, Pages 1161-1163

  Neergaard Petersen, Søs ^a   Hvas, Anne Mette ^b   Ajjan, Ramzi ^a   Larsen, Sanne Bøjet ^a   Würtz, Morten ^a   Kristensen, Steen Dalby ^a   Grove, Erik Lerkevang ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOGEN; HEMOGLOBIN; FIBRIN;

ADULT; BLOOD CLOT LYSIS; CARDIAC PATIENT; CORONARY ARTERY DISEASE; ERYTHROCYTE COUNT; FEMALE; FIBRIN CLOT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PLATELET TURNOVER; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; AGED; BLOOD; CHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; THROMBOCYTE;

AGED; BLOOD PLATELETS; CORONARY ARTERY DISEASE; FEMALE; FIBRIN; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT;

EID: 84900501115     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.03.039     Document Type: Letter

References (18)

1. R. Lozano, M. Naghavi, K. Foreman, S. Lim, K. Shibuya, and V. Aboyans et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 9859 2012 2095 2128
2. C. Baigent, L. Blackwell, R. Collins, J. Emberson, J. Godwin, and R. Peto et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials Lancet 373 9678 2009 1849 1860
3. M. Wurtz, and E.L. Grove Interindividual variability in the efficacy of oral antiplatelet drugs: definitions, mechanisms and clinical importance Curr Pharm Des 18 33 2012 5344 5361
4. E.L. Grove, A.M. Hvas, S.B. Mortensen, S.B. Larsen, and S.D. Kristensen Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease J Thromb Haemost 9 1 2011 185 191
5. S. Guthikonda, E.I. Lev, R. Patel, T. DeLao, A.L. Bergeron, and J.F. Dong et al. Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin J Thromb Haemost 5 3 2007 490 496
6. A. Undas, D. Plicner, E. Stepien, R. Drwila, and J. Sadowski Altered fibrin clot structure in patients with advanced coronary artery disease: a role of C-reactive protein, lipoprotein(a) and homocysteine J Thromb Haemost 5 9 2007 1988 1990
7. A. Undas, M. Kolarz, G. Kopec, and W. Tracz Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality Nephrol Dial Transplant 23 6 2008 2010 2015
8. K. Leander, M. Blomback, H. Wallen, and S. He Impaired fibrinolytic capacity and increased fibrin formation associate with myocardial infarction Thromb Haemost 107 6 2012 1092 1099
9. E.L. Grove, A.M. Hvas, and S.D. Kristensen Immature platelets in patients with acute coronary syndromes Thromb Haemost 101 1 2009 151 156
10. A.M. Carter, C.M. Cymbalista, T.D. Spector, and P.J. Grant Heritability of clot formation, morphology, and lysis: the EuroCLOT study Arterioscler Thromb Vasc Biol 27 12 2007 2783 2789
11. S. Neergaard-Petersen, R. Ajjan, A.M. Hvas, K. Hess, S.B. Larsen, and S.D. Kristensen et al. Fibrin clot structure and platelet aggregation in patients with aspirin treatment failure PLoS One 8 8 2013 e71150
12. M. Wurtz, A.M. Hvas, S.D. Kristensen, and E.L. Grove Platelet aggregation is dependent on platelet count in patients with coronary artery disease Thromb Res 129 1 2012 56 61
13. E.L. Grove, M. Wurtz, A.M. Hvas, and S.D. Kristensen Increased platelet turnover in patients with previous definite stent thrombosis J Thromb Haemost 9 7 2011 1418 1419
14. A.A. Amelot, M. Tagzirt, G. Ducouret, R.L. Kuen, and B.F. Le Bonniec Platelet factor 4 (CXCL4) seals blood clots by altering the structure of fibrin J Biol Chem 282 1 2007 710 720
15. J.P. Collet, G. Montalescot, C. Lesty, and J.W. Weisel A structural and dynamic investigation of the facilitating effect of glycoprotein IIb/IIIa inhibitors in dissolving platelet-rich clots Circ Res 90 4 2002 428 434
16. N.J. Mutch, R. Engel, W.S. Uitte de, H. Philippou, and R.A. Ariens Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin Blood 115 19 2010 3980 3988
17. M.M. Aleman, C. Gardiner, P. Harrison, and A.S. Wolberg Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability J Thromb Haemost 9 11 2011 2251 2261
18. H. Brogren, L. Karlsson, M. Andersson, L. Wang, D. Erlinge, and S. Jern Platelets synthesize large amounts of active plasminogen activator inhibitor 1 Blood 104 13 2004 3943 3948